A. Bush (London, United Kingdom), P. M. Gustafsson (Skövde, Sweden)
DNA fingerprinting of pseudomonas aeruginosa in cystic fibrosis patients: risk assessment of cross-infection in a CF centre S. G. P. M. Van daele, P. Haerynck, P. Schelstraete, G. Claeys, M. Vaneechoutte, F. De Baets (Gent, Belgium)
| |
DNA fingerprinting of Pseudomonas aeruginosa (Pa) in cystic fibrosis patients: risk assessment of cross-colonisation in a CF revalidation centre F. M. De Baets, S. Van Daele, P. Schelstraete, M. Vaneechoutte, G. Claeys, A. S. Moring, H. Franckx (Gent, De Haan, Belgium)
| |
Diagnostic values of airway samples and serum antibodies for P. aeruginosa in cystic fibrosis A. Jung, F. Ratjen, M. Griese, E. Rietschel, M. Ballmann, G. Döring, K. P. Paul (Berlin, Munich, Germany)
| |
Prospective study of nontuberculous mycobacteria (NTM) isolates in children with cystic fibrosis M. Ballmann, S. Junge (Hannover, Germany)
| |
Changes in ventilatory mechanics with increasing disease severity in children and adolesecents with cystic fibrosis (CF) N. Hart, M. I. Polkey, A. Clement, M. Boule, J. Moxham, F. Lofaso, B. Fauroux (London, United Kingdom; Paris, Garches, France)
| |
Increased ventilation inhomogeneity in infants with Cystic Fibrosis (CF) H. Ljungberg, P. Gustafsson, G. Hülskamp, A. F. Hoo, J. Pillow, J. Stocks (London, United Kingdom; Gothenburg, Sweden)
| |
Multiple breath washout in healthy pre-school children and those with cystic fibrosis (CF) P. Aurora, C. Oliver, P. M. Gustafsson, J. Stocks (London, United Kingdom; Gothenburg, Sweden)
| |
Progression of structural lung damage on high resolution CT in cystic fibrosis children with stable lung function P. A. de Jong, Y. Nakano, M. H. Lequin, P. D. Pare, H. A. W. M. Tiddens (Rotterdam, The Netherlands; Vancouver, Canada)
| |